Post by Visium

After three energizing days at BioTechX Europe, one thing is clear - AI is transforming Life Sciences at an unprecedented speed. Leaders from Roche, Novartis, Novo Nordisk, Boehringer Ingelheim, Ferring Pharmaceuticals, and many others joined us at our booth to explore how AI can accelerate discovery, improve patient outcomes, and bring life-changing breakthroughs to patients faster. Our roundtable explored real-world compliance challenges that pharma leaders face. The keynote demonstrated how AI is reshaping protein design by flagging risk early, accelerating lead selection, and bringing predictability to what once was pure experimentation. The highlight? Seeing pharma leaders react to the reveal of Visium’s new AI platform, developed to operationalize high-stakes use cases and deliver 10X the value at a fraction of the cost while maintaining full transparency and compliance. Behind it all is Agentic AI and our approach to building systems that think, verify, and scale safely. Because for us, it’s not how we build AI. It’s about why: to help organizations unlock value at scale, accelerate innovation, and ultimately improve lives. We’d love to hear your perspective. Where do you see the biggest untapped potential for AI in Life Sciences today? And what’s still holding it back? 👇🏻 Read the full article: https://lnkd.in/e6k45Qar

Video Content